Article: Foundayo: Oral GLP-1 Demonstrated Up to 14% Weight Loss for All Women

A new analysis found that the diabetes medication orforglipron (Foundayo), an oral GLP-1, helped women lose up to 14% of their body weight, regardless of their menopausal status.